Trial | NCT00659919  Report issue

Title

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    trazodone ...

  • Study Participants

    13
Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.
Study Started
Nov 30
2000
Primary Completion
Dec 31
2003
Study Completion
Dec 31
2003
Last Update
Jun 17
2008
Estimate

Drug Placebo

Drug Trazodone

Placebo Placebo Comparator

The patients in this arm received placebo

Trazodone Active Comparator

The patients on this arm received Trazodone for 3 consecutive days

Criteria 

Inclusion Criteria:

Patients with akathisia according to DSM-IV criteria at least mild akathisia.

Exclusion Criteria:

Change of pharmacologic regimen 7 days prior to study entry
Significant systemic disease
The presence of chronic akathisia
Patients unable to cooperate
No Results Posted